The Carestream solutions installed at Robarts are the DRX-Evolution Plus System with state-of-the-art Dual Energy (DE) acquisition and Digital Tomosynthesis (DT) image acquisition software. In comparison to conventional radiography, DT provides more accurate depth location while improving the contrast visualization of local structures—removing overlying and underlying anatomy. DE allows for improved detection sensitivity for abnormalities in the lung and improved assessment at the entrance exposure of a standard chest X-ray, which typically is a challenging image acquisition.
“The combination of these features facilitates comprehensive high-resolution structural and functional imaging, combined with tomographic capabilities that improve on conventional X-ray images by removing overlapping structures and, in certain scenarios, provides information similar to CT but at a much lower radiation dose,” said Matthew Teeter, Ph.D., Associate Professor, Medical Biophysics at Schulich Medicine & Dentistry.
Carestream’s solutions are part of Robarts’ larger research initiative to benefit patients involved in clinical studies, and optimize patient’s and clinician’s time. The center also furthers collaborations between scientists, clinicians and technology developers and allows for imaging equipment to be used in novel ways, leading to greater improvements in patient care.
“It all comes back to why we are doing research,” Dr. Paul said. “Everything we do is focused on making life better for patients.”
About Robarts Research Institute
Robarts is the research institute of Schulich School of Medicine & Dentistry at Western University in London, Ontario. The medical research facility opened in1986 and is now home to more than 600 researchers who investigate some of the most debilitating diseases.
About Carestream Health
Carestream is a worldwide provider of medical imaging systems; X-ray imaging systems for non-destructive testing; and precision contract coating services for a wide range of industrial, medical, electronic, and other applications—all backed by a global service and support network.
Back to HCB News